Ceryvyn Therapeutics Limited CYVNY
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 0.80% | -6.87% | 0.85% | -54.75% | 5.12% |
| Total Receivables | 0.80% | 79.04% | 0.84% | -94.52% | 5.12% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 0.79% | -51.95% | 0.85% | 53.39% | 5.13% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 0.80% | -7.55% | 0.85% | -58.64% | 5.12% |
|
|
|||||
| Total Current Assets | 0.80% | -7.55% | 0.85% | -58.64% | 5.12% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 0.80% | -7.55% | 0.85% | -58.64% | 5.12% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | -- | -- | -- | -- | 5.12% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | 5.12% |
| Total Finance Division Other Current Liabilities | 0.80% | 30.92% | 0.85% | -87.64% | 5.12% |
| Total Other Current Liabilities | 0.80% | 30.92% | 0.85% | -87.64% | 5.12% |
| Total Current Liabilities | 0.80% | 30.92% | 0.85% | -99.53% | 5.12% |
|
|
|||||
| Total Current Liabilities | 0.80% | 30.92% | 0.85% | -99.53% | 5.12% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 0.80% | 30.92% | 0.85% | -99.53% | 5.12% |
|
|
|||||
| Common Stock & APIC | 0.80% | 2.89% | 0.85% | 1.51% | 5.12% |
| Retained Earnings | -0.80% | -3.91% | -0.85% | 30.39% | -5.12% |
| Treasury Stock & Other | 0.80% | 9.37% | 0.85% | -2.32% | 5.12% |
| Total Common Equity | 0.80% | -9.63% | 0.85% | 111.08% | -5.12% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 0.80% | -9.63% | 0.85% | 111.08% | -5.12% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 0.80% | -9.63% | 0.85% | 111.08% | -5.12% |
|
|
|||||